טוען...
Metabolic actions of angiotensin receptor antagonists: PPAR-γ agonist actions or a class effect?
Accumulating basic and clinical data support the hypothesis that angiotensin receptor blockers have beneficial effects on glucose and lipid metabolism that are not shared by other classes of antihypertensive agents. These metabolic actions might only partially be shared by angiotensin-converting enz...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2007
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2930911/ https://ncbi.nlm.nih.gov/pubmed/17303473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2006.11.008 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|